Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin.

King EM, Mazor R, Çuburu N, Pastan I.

J Immunol. 2018 Mar 15;200(6):2038-2045. doi: 10.4049/jimmunol.1701430. Epub 2018 Feb 5.

PMID:
29431691
2.

Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.

Mazor R, King EM, Onda M, Cuburu N, Addissie S, Crown D, Liu XF, Kishimoto TK, Pastan I.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E733-E742. doi: 10.1073/pnas.1717063115. Epub 2018 Jan 8. Review.

3.

Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins.

Çuburu N, Khan S, Thompson CD, Kim R, Vellinga J, Zahn R, Lowy DR, Scheper G, Schiller JT.

Int J Cancer. 2018 Apr 1;142(7):1467-1479. doi: 10.1002/ijc.31166. Epub 2017 Dec 1.

PMID:
29159802
4.

Moving forward with human papillomavirus immunotherapies.

Çuburu N, Schiller JT.

Hum Vaccin Immunother. 2016 Nov;12(11):2875-2880. Epub 2016 Jul 7.

5.

Erratum for Pastrana et al., BK Polyomavirus Genotypes Represent Distinct Serotypes with Distinct Entry Tropism.

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB.

J Virol. 2015 Dec 17;90(1):624. doi: 10.1128/JVI.02585-15. Print 2016 Jan 1. No abstract available.

6.

Absence of both Sos-1 and Sos-2 in peripheral CD4(+) T cells leads to PI3K pathway activation and defects in migration.

Guittard G, Kortum RL, Balagopalan L, Çuburu N, Nguyen P, Sommers CL, Samelson LE.

Eur J Immunol. 2015 Aug;45(8):2389-95. doi: 10.1002/eji.201445226. Epub 2015 Jun 5.

7.

Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.

Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M Jr, Lifson JD, Xenophontos AM, Venzon D, Robert-Guroff M, Graham BS, Lowy DR, Schiller JT, Franchini G.

J Immunol. 2014 Dec 15;193(12):6172-83. doi: 10.4049/jimmunol.1401504. Epub 2014 Nov 14.

8.

Mouse model of cervicovaginal papillomavirus infection.

Çuburu N, Cerio RJ, Thompson CD, Day PM.

Methods Mol Biol. 2015;1249:365-79. doi: 10.1007/978-1-4939-2013-6_27.

PMID:
25348320
9.
10.

BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB.

J Virol. 2013 Sep;87(18):10105-13. doi: 10.1128/JVI.01189-13. Epub 2013 Jul 10. Erratum in: J Virol. 2016 Jan 1;90(1):624.

11.

Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood.

Saletti G, Çuburu N, Yang JS, Dey A, Czerkinsky C.

Nat Protoc. 2013 Jun;8(6):1073-87. doi: 10.1038/nprot.2013.058. Epub 2013 May 9.

PMID:
23660756
12.

Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT.

J Clin Invest. 2012 Dec;122(12):4606-20. doi: 10.1172/JCI63287. Epub 2012 Nov 12.

13.

B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.

Anjuère F, Bekri S, Bihl F, Braud VM, Cuburu N, Czerkinsky C, Hervouet C, Luci C.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:117-22. doi: 10.1111/j.1469-0691.2012.03995.x. Epub 2012 Aug 10. Review.

14.

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.

Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB.

PLoS Pathog. 2012;8(4):e1002650. doi: 10.1371/journal.ppat.1002650. Epub 2012 Apr 12.

15.

Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.

Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, Lowy DR, Schiller JT, Franchini G.

J Immunol. 2012 Jan 15;188(2):714-23. doi: 10.4049/jimmunol.1101404. Epub 2011 Dec 14.

16.

Genital delivery of virus-like particle and pseudovirus-based vaccines.

Cuburu N, Chackerian B.

Expert Rev Vaccines. 2011 Sep;10(9):1245-8. doi: 10.1586/erv.11.104. No abstract available.

17.

Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control.

Cha HR, Ko HJ, Kim ED, Chang SY, Seo SU, Cuburu N, Ryu S, Kim S, Kweon MN.

J Immunol. 2011 Sep 15;187(6):3044-52. doi: 10.4049/jimmunol.1100402. Epub 2011 Aug 10.

18.

Sublingual vaccination.

Czerkinsky C, Cuburu N, Kweon MN, Anjuere F, Holmgren J.

Hum Vaccin. 2011 Jan 1;7(1):110-4. Epub 2011 Jan 1. Review.

PMID:
21263223
19.

Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract.

Hervouet C, Luci C, Cuburu N, Cremel M, Bekri S, Vimeux L, Marañon C, Czerkinsky C, Hosmalin A, Anjuère F.

Vaccine. 2010 Aug 2;28(34):5582-90. doi: 10.1016/j.vaccine.2010.06.033. Epub 2010 Jun 25.

PMID:
20600505
20.

Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid.

Pastrana DV, Pumphrey KA, Cuburu N, Schowalter RM, Buck CB.

Virology. 2010 Sep 15;405(1):20-5. doi: 10.1016/j.virol.2010.06.022. Epub 2010 Jul 3.

21.

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB.

Mucosal Immunol. 2010 Sep;3(5):475-86. doi: 10.1038/mi.2010.31. Epub 2010 Jun 16.

22.

Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

Cuburu N, Kweon MN, Hervouet C, Cha HR, Pang YY, Holmgren J, Stadler K, Schiller JT, Anjuère F, Czerkinsky C.

J Immunol. 2009 Dec 15;183(12):7851-9. doi: 10.4049/jimmunol.0803740.

23.

CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.

Song JH, Kim JI, Kwon HJ, Shim DH, Parajuli N, Cuburu N, Czerkinsky C, Kweon MN.

J Immunol. 2009 Jun 1;182(11):6851-60. doi: 10.4049/jimmunol.0803568.

24.

Preclinical targeting of NF-kappaB and FLT3 pathways in AML cells.

Griessinger E, Frelin C, Cuburu N, Imbert V, Dageville C, Hummelsberger M, Sirvent N, Dreano M, Peyron JF.

Leukemia. 2008 Jul;22(7):1466-9. doi: 10.1038/sj.leu.2405102. Epub 2008 Jan 31. No abstract available.

PMID:
18239622
25.

Sublingual vaccination with influenza virus protects mice against lethal viral infection.

Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, Czerkinsky C, Kweon MN.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1644-9. doi: 10.1073/pnas.0708684105. Epub 2008 Jan 28.

26.

Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.

Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, Sun JB, Hofman P, Holmgren J, Anjuère F, Czerkinsky C.

Vaccine. 2007 Dec 12;25(51):8598-610. Epub 2007 Oct 25.

PMID:
17996991
27.
28.

Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Brest P, Bétis F, Cuburu N, Selva E, Herrant M, Servin A, Auberger P, Hofman P.

Infect Immun. 2004 Oct;72(10):5741-9.

29.

Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation.

Ciofani M, Schmitt TM, Ciofani A, Michie AM, Cuburu N, Aublin A, Maryanski JL, Zúñiga-Pflücker JC.

J Immunol. 2004 May 1;172(9):5230-9.

Supplemental Content

Loading ...
Support Center